Clinical Trial Update: Cardiogenesis Transmyocardial Revascularization Registry

View source ↗

Summary

The Cardiogenesis Transmyocardial Revascularization trial for Class IV angina has completed and posted results on ClinicalTrials.gov in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease

Snippet

Sponsor: Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. | Conditions: Class IV Angina | Status: COMPLETED | Results posted: 2016-08-15